Similar to other studies [47,48], the fluctuation of the standard tumor biomarkers S-CEA and S-CA19.9 did not always reflect the clinical status of patients, highlighting the need to find other more specific biomarkers. The gene discussed is CEACAM5; the disease is neoplasm.